ArticleIMA fungus2021
How to publish a new fungal species, or name, version 3.0.
Article in IMA fungus, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 69 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
69 citing papers in PubMed.
- Novel insights into the phylogenetic and metabolic diversity of preussia-like fungi.Studies in mycology · 2026Article
- Taxonomic revision of the genusPersoonia · 2026Article
- Biogeography and host associations of Russula subsection Xerampelinae based on large-scale analysis of UNITE sequence data.The New phytologist · 2026Article
- Should describing a new species be science or data release? Rethinking introductions in fungal taxonomy.IMA fungus · 2026Article
- Advancing the taxonomy ofIMA fungus · 2026Review
- Dirt or type? Clarifying fungal nomenclature in the DNA age.IMA fungus · 2026Article
- Integrative taxonomy reveals two new species of Itajahya Möller (Phallaceae, Phallales) in Brazil.PloS one · 2026Article
- Article
- Article
- Molecular characterization reveals threeFrontiers in plant science · 2026Article
- Putative palm pathogens: Novel species and new host records of leaf disease-associated microfungi (Ascomycota) onMycoKeys · 2026Article
- Diversity ofJournal of fungi (Basel, Switzerland) · 2025Article
- From chaos to tranquillity: a modern approach to the identification, nomenclature and phylogeny ofStudies in mycology · 2025Article
- Global diversity analysis of plant-associatedStudies in mycology · 2025Article
- A taxonomic revision ofPersoonia · 2025Article
- Ascomycota: Diversity, Taxonomy and Phylogeny, 2nd Edition: Editorial.Journal of fungi (Basel, Switzerland) · 2025Article
- REVIEW AND RECOMMENDATIONS FOR HEALTH INFORMATICS IN SUB-SAHARAN AFRICAN COUNTRIES: BETWEEN OPPORTUNITIES AND CHALLENGES.Medical research archives · 2025Article
- Article
- A Review of the Biotechnological Potential of Cave Fungi: A Toolbox for the Future.Journal of fungi (Basel, Switzerland) · 2025Review
- Three new species and two new records of the genusMycoKeys · 2025Article
9 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
19 authors.
Funding
Abstract
It is now a decade since The International Commission on the Taxonomy of Fungi (ICTF) produced an overview of requirements and best practices for describing a new fungal species. In the meantime the International Code of Nomenclature for algae, fungi, and plants (ICNafp) has changed from its former name (the International Code of Botanical Nomenclature) and introduced new formal requirements for valid publication of species scientific names, including the separation of provisions specific to Fungi and organisms treated as fungi in a new Chapter F. Equally transformative have been changes in the data collection, data dissemination, and analytical tools available to mycologists. This paper provides an updated and expanded discussion of current publication requirements along with best practices for the description of new fungal species and publication of new names and for improving accessibility of their associated metadata that have developed over the last 10 years. Additionally, we provide: (1) model papers for different fungal groups and circumstances; (2) a checklist to simplify meeting (i) the requirements of the ICNafp to ensure the effective, valid and legitimate publication of names of new taxa, and (ii) minimally accepted standards for description; and, (3) templates for preparing standardized species descriptions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.